- Home
- RGA vs PODD Comparison
RGA vs PODD Comparison
Compare RGA & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGA
- PODD
- Stock Information
- Founded
- RGA 1973
- PODD 2000
- Country
- RGA United States
- PODD United States
- Employees
- RGA N/A
- PODD N/A
- Industry
- RGA Life Insurance
- PODD Medical/Dental Instruments
- Sector
- RGA Finance
- PODD Health Care
- Exchange
- RGA Nasdaq
- PODD Nasdaq
- Market Cap
- RGA 14.1B
- PODD 16.5B
- IPO Year
- RGA 1993
- PODD 2007
- Fundamental
- Price
- RGA $223.23
- PODD $275.81
- Analyst Decision
- RGA Buy
- PODD Buy
- Analyst Count
- RGA 14
- PODD 16
- Target Price
- RGA $228.79
- PODD $271.19
- AVG Volume (30 Days)
- RGA 446.2K
- PODD 533.0K
- Earning Date
- RGA 02-06-2025
- PODD 02-20-2025
- Dividend Yield
- RGA 1.60%
- PODD N/A
- EPS Growth
- RGA N/A
- PODD 235.68
- EPS
- RGA 10.91
- PODD 5.74
- Revenue
- RGA $21,873,000,000.00
- PODD $1,983,900,000.00
- Revenue This Year
- RGA N/A
- PODD $23.56
- Revenue Next Year
- RGA N/A
- PODD $18.07
- P/E Ratio
- RGA $20.43
- PODD $48.09
- Revenue Growth
- RGA 22.08
- PODD 27.42
- 52 Week Low
- RGA $163.81
- PODD $160.19
- 52 Week High
- RGA $233.81
- PODD $279.77
- Technical
- Relative Strength Index (RSI)
- RGA 59.27
- PODD 61.05
- Support Level
- RGA $213.35
- PODD $260.84
- Resistance Level
- RGA $223.28
- PODD $274.45
- Average True Range (ATR)
- RGA 4.43
- PODD 7.44
- MACD
- RGA 1.29
- PODD 0.65
- Stochastic Oscillator
- RGA 86.41
- PODD 88.34
About RGA Reinsurance Group of America Incorporated
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.